MELANIE NUSS: Open Payments
NPI 1710916978 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 39 payments from 10 companies in 2025. Trend: 2023 $744 · 2024 $1,086 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $238 |
| PFIZER INC. | 4 | $80 |
| Janssen Biotech, Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $72 |
| UCB, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Amgen Inc. | 2 | $34 |
| Incyte Corporation | 1 | $28 |
| LEO Pharma Inc. | 1 | $20 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
Products named: RINVOQ, CIBINQO, TREMFYA, SKYRIZI, Bimzelx, TALTZ, BOTOX, OTEZLA.
Industry payments across LA — which companies pay providers there.
